ICA Group Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-28
Closed -$16.3K 1282
2024
Q1
$16.3K Sell
28
-8
-22% -$4.49K ﹤0.01% 797
2023
Q4
$19.1K Buy
+36
New +$17.4K ﹤0.01% 740
2023
Q3
Sell
-40
Closed -$20.9K 1130
2023
Q2
$20.9K Sell
40
-3
-7% -$1.62K 0.01% 682
2023
Q1
$24.8K Sell
43
-1
-2% -$564 0.01% 625
2022
Q4
$24.2K Sell
44
-1,491
-97% -$790K 0.01% 654
2022
Q3
$779K Buy
1,535
+42
+3% +$23.5K 0.17% 135
2022
Q2
$879K Buy
1,493
+27
+2% +$14.9K 0.16% 132
2022
Q1
$811K Buy
+1,466
New +$842K 0.15% 140

Other funds holding TMO

ICA Group Wealth Management's TMO Position: Q2 2024 in Review

ICA Group Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 28 shares — an estimated $16.3K sold.

ICA Group Wealth Management first reported a position in TMO in Q1 2022 and held it in 8 quarters. The position peaked at $879K in Q2 2022. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • ICA Group Wealth Management reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 28 Thermo Fisher Scientific shares in Q2 2024, an estimated $16.3K.
  • ICA Group Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 8 quarters.
  • ICA Group Wealth Management's Thermo Fisher Scientific position peaked at $879K in Q2 2022.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.